Recently, the presence of anti-PTX3 autoantibodies has been described in RA and shown to positively correlate with PTX3 serum levels, disease activity and circulating levels of pro-inflammatory cytokines, such as IL-6 or IL-1β (41), further confirming PTX3 immunogenicity in the RA context. Here, IL6 is linked to rheumatoid arthritis.